Most cases of CML can be diagnosed using peripheral blood findings combined with molecular genetic techniques that detect t(9; 22) (q34.1; q11.2) or, more specifically, BCR::ABL1. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.